Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Oskar Hansson, Nicolas R. Barthélemy et al.|JAMA Neurology|2024Cited by 109
Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno‐Sandwich AssayNicholas J. Ashton, Henrik Zetterberg, Andréa Lessa Benedet et al.|Alzheimer s & Dementia|2025Cited by 20
Plasma tau biomarkers for biological staging of Alzheimer’s diseaseLaia Montoliu‐Gaya, Oskar Hansson, Gemma Salvadó et al.|Nature Aging|2025Cited by 17
Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’Sophia Weiner, Johan Gobom, Mathias Sauer et al.|Molecular Neurodegeneration|2025Cited by 4
Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiologyGleb Bezgin, Pedro Rosa‐Neto, Tharick A. Pascoal et al.|European Journal of Nuclear Medicine and Molecular Imaging|2025Cited by 3